Search results
Results from the WOW.Com Content Network
An epinephrine autoinjector (or adrenaline autoinjector, also known by the trademark EpiPen) is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.
Neffy is a nasal spray that’s designed to be used in place of an EpiPen to treat people who are experiencing a severe allergic reaction. (Worth noting: Neffy and EpiPen are made by different ...
Epinephrine is also used as a bronchodilator for asthma if specific β 2 agonists are unavailable or ineffective. [39] Because of the high intrinsic efficacy (receptor binding ability) of epinephrine, high drug concentrations cause adverse side effects when treating asthma. The value of using nebulized epinephrine in acute asthma is unclear. [40]
A variety of autoinjectors in use with the US Armed Forces. Epinephrine autoinjectors are often prescribed to people who are at risk for anaphylaxis. Brand names include Anapen, EpiPen, Emerade, and Auvi-Q. [citation needed] Rebiject, Rebiject II and Rebidose autoinjectors for Rebif, the drug for interferon beta-1a used to treat multiple sclerosis.
The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has been approved by the Food and Drug Administration to treat anaphylaxis.. Neffy, a nasal spray that ...
The trial was designed to compare single doses of AQST-109 to EpiPen 0.3mg and epinephrine 0.3mg intramuscular (IM) injection and repeat doses of AQST-109 to repeat doses of epinephrine 0.3mg IM ...
Common treatments for the condition include taking regular anti-histamines, the use of an epinephrine injector (commonly known as an EpiPen), and through abstinence of exercise. In a 1999 study, 56% of sufferers reported the use of anti-histamines as treatment for their EIA, and 31% reported having treated the condition with epinephrine. [6]
The EpiPen, and its maker Mylan Pharmaceuticals, have been all over the news as of late. But price hikes on crucial medicine go far beyond the Epi-Pen.